XETRA · DE · bbbiotech.ch
47.10EUR-1.57%Mkt Cap: 2.60B EURP/E: —Last update: 2026-06-01
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medica…
Indicators:|
Key Statistics
Company
Market Cap2.60B EUR
Enterprise Value-553.39K EUR
Revenue (TTM)616.88M EUR
Gross Profit616.88M EUR
Net Income (TTM)578.13M EUR
Revenue/Share11.23 EUR
Last Price47.10 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryDE
Sector—
Industry—
ISINCH0038389992
Valuation
P/E (Trailing)—
P/E (Forward)21.80
PEG—
EV/EBITDA—
EV/Revenue-0.00
P/S4.28
P/B0.92
EPS (TTM)-8.60
EPS (Forward)2.19
52W Range
30.9072% of range53.50
52W High53.50 EUR
52W Low30.90 EUR
Profitability
Gross Margin100.00%
Oper. Margin-638.71%
EBITDA Margin0.00%
Profit Margin98.49%
ROE20.81%
ROA20.75%
Growth
Revenue Growth1311.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF393.70M EUR
CapEx (TTM)—
FCF Margin363.87%
FCF Yield86.41%
Net Debt-2.64B EUR
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio336.03
Quick Ratio335.84
Book Value/Sh52.22 EUR
Cash/Share47.86 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate2.250 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio87.34%
Ex-Div DateMar 23, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)62.00 EUR
Target Range62.00 EUR – 62.00 EUR
# Analysts1
Ownership
Shares Out.55.15M
Float—
Insiders0.08%
Institutions18.33%
Technical
SMA 5033.40 (+41.0%)
SMA 20033.40 (+41.0%)
Beta0.63
S&P 52W Chg27.70%
Avg Vol (30d)6.51K
Avg Vol (10d)0
Technical Indicators
RSI (14)42.7
MACD-0.2475
MACD Signal-0.2127
MACD Hist.-0.0348
BB Upper50.05 EUR
BB Middle48.65 EUR
BB Lower47.24 EUR
BB Width5.79%
ATR (14)0.9844 EUR
Vol Ratio (20d)5.11x